Detect signs of cardiovascular risk from a 30-second single-lead ECG

TCC reads a quick single-lead ECG and gives you a Low, Moderate or High risk category in seconds. Makes it easy to decide what to do next with each patient.

Trusted by healthcare teams delivering earlier cardiac intervention.

- Clinical Validation

Validated on held-out data. Reported with confidence intervals.

Built on millions of single-lead ECGs and measured against recordings the model never saw in training.

Millions of
ECG recordings
Diverse
populations
Held-out
benchmarks
0.909
AUROC — overall discrimination
95% CI 0.905–0.9131
85.9%
Sensitivity, high risk — true high-risk captured
95% CI 84.6–87.0%1
92.2%
Specificity, high risk — correctly flagged
95% CI 91.6–92.9%1
90.2%
Sensitivity, low risk — true low-risk identified
95% CI 89.2–91.2%1
INTENDED USE AND LIMITATIONS

A result that is not flagged high risk does not exclude disease, and does not replace a 12-lead ECG or clinical assessment.

Screening and risk stratification only — not a diagnosis.

Additive only — cannot downgrade a clinical decision.

Requires clinical consultation by a qualified professional.

Not tested under 18 or in pregnancy.

Not for patients with pacemakers or ICDs.

Classifiable waveforms required.

Tricog CardioCheck is a CDSCO-certified, cloud-based Software as a Medical Device (SaMD), intended for use by healthcare professionals, patients with known or suspected cardiac conditions, and health-conscious individuals.

- The Gap

The gap is detection,
not treatment.

Once a cardiac condition is spotted, the care already exists. The gap is discovery — most people never know they’re at risk, so they never reach a doctor at all.

110 million

Indians live with cardiovascular disease today — a number set to more than double by 2050.¹

1 in 4

deaths in India is cardiac.²

About 1 in 5

of the world's cardiac deaths happen in India.³

Detected

The few who get diagnosed.

Undetected

TThe millions who don’t..

- HOW TCC IS DIFFERENT

Built for clinical screening, not consumer monitoring.

Consumer gadgets watch one person who already suspects a problem. Traditional triage only tests the patients a doctor already worries about. TCC screens everyone, inside a normal visit.

Tricog CardioCheck
ECG in Watch
Traditional Triage
Other 1-Lead ECGs
Who it's for Every patient at the clinic Consumer smartwatch users Only patients a doctor suspects People who already know they have a condition
What it looks for Dozens of findings across Low / Moderate / High AFib + irregular rhythm Depends on symptoms 4 rhythms only
What you get back A clear risk level + the next step A rhythm alert A judgement call A rhythm label
Fits the vitals workflow
Yes, adds ~30–50s
Cardiologist on site
Not needed
Required
Time to result ~10s (after a 30-sec ECG)
Device OMRON Complete (only) Consumer smartwatch 12-lead machine Own device
Regulatory CDSCO-certified, Class B SaMD Consumer Consumer
- IN THE FLOW OF A NORMAL VISIT

Fits the existing outpatient workflow.

A patient checking in with a clinician at a front desk
01

Check in as usual.

The patient arrives for whatever brought them in.

A patient checking in with a clinician at a front desk
02

During routine vitals.

Fingers and thumbs on the OMRON pads, sit still for 30 seconds — alongside BP, SpO2, height and weight. No wires, no gel.

A patient checking in with a clinician at a front desk
03

A result in seconds.

A risk level — Low, Moderate or High — appears on the staff member’s phone.

A patient checking in with a clinician at a front desk
04

A clear next step.

Low: carry on. 
Moderate or High: sent for a 12-lead ECG and the doctor, soon.

June 2025 — a village clinic outside Bengaluru.

400+ people screened in a single day. TCC, then a 12-lead ECG, then the doctor — a complete care journey, in the field.

Read the story

Everything the clinician needs at the point of care

Request a Live Demo

The output is a structured triage signal that arrives while the patient is still in front of you.

Risk Category: Low, Moderate or High.
Clinical Insights: the waveform patterns that drove the classification. Referral Guidance: the recommended next action (12-lead ECG and clinical review when indicated)

Low Risk Moderate Risk High Risk

Built for where care actually happens.

The same 30-second capture, adapted to your setting — from high-volume OPDs to rural health centres.

High-volume OPD
High-volume OPD High volume

Screens every patient at intake without slowing the queue, so priority follows cardiac risk, not arrival order.

Corporate screening
Corporate screening Large cohorts

Adds a cardiac risk category to routine check-ups — the asymptomatic group conventional screening misses.

Rural PHC
Rural PHC No cardiologist on site

With no cardiologist on site, frontline staff get an objective basis for referral.

GP clinic
GP clinic No diagnostics onsite

Single-doctor practices with no diagnostics get a structured way to decide who to refer onward.

Health camps
Health camps Portable & fast

Portable and usable by non-specialist staff, with the risk category available immediately.

Know more

Questions, answered.

TCC is a cardiac risk screening tool designed to flag patients at moderate or high cardiovascular risk, including those who may otherwise be missed through the traditional clinical pathway. It helps clinicians identify patients who may need further evaluation or appropriate follow-up.
A single-lead ECG is a quick, 30-second recording of the heart’s electrical activity. It captures clinically relevant ECG signals that can help identify potential cardiac risk. TCC analyzes this ECG using its algorithm to assess the patient’s cardiovascular risk and classify it as Low, Moderate, or High.
TCC enables a single-lead ECG to be used not just to capture a signal but also as a screening tool to help flag patients who may otherwise be missed in the traditional clinical pathway.
No. TCC is a cardiac risk screening and triage tool, not a diagnostic tool.
A High Risk result indicates that the patient may require further cardiac evaluation. The patient should be referred to a doctor for clinical assessment and, where appropriate, a 12-lead ECG and further evaluation as soon as possible.

TCC does not diagnose a cardiac condition. The final assessment and next steps are determined by the treating clinician based on the patient’s symptoms, history, examination, and other clinical findings.
TCC currently supports ECG data recorded using OMRON Healthcare’s Complete™ blood pressure monitors with integrated ECG monitoring.

Through our partnership with OMRON Healthcare, ECG data captured by these devices is securely transmitted to the cloud and analyzed by the TCC algorithm to provide a Low, Moderate, or High cardiovascular risk assessment in approximately 10 seconds.
Yes. TCC is designed with healthcare data privacy and security in mind and complies with applicable HIPAA, GDPR, and CDSCO requirements. Access to patient information is restricted based on authorized roles, helping ensure that sensitive health data is only available to those who need it.
No. TCC does not replace a traditional 12-lead ECG. TCC is a rapid cardiac risk screening tool designed to help identify patients who may need further cardiac evaluation.

A 12-lead ECG provides a more comprehensive assessment of the heart’s electrical activity and may be recommended by a clinician following a TCC result, based on the patient’s symptoms, history, and clinical findings.
TCC was developed using a foundational dataset of millions of ECG recordings, with training designed to account for class imbalance so that less common, high-risk cardiac patterns were adequately represented.

TCC is also validated on separate ECG data to assess how reliably it identifies different levels of cardiac risk.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed tincidunt magna sit amet posuere malesuada.